Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Carrie Fry"'
Autor:
Iris Chen, Leila Khaki, Jane C. Lindsey, Carrie Fry, Matthew M. Cousins, Robert F. Siliciano, Avy Violari, Paul Palumbo, Susan H. Eshleman
Publikováno v:
PLoS ONE, Vol 8, Iss 12 (2013)
Externí odkaz:
https://doaj.org/article/5a578ad464ba4572b0545d9afc463166
Autor:
Iris Chen, Leila Khaki, Jane C Lindsey, Carrie Fry, Matthew M Cousins, Robert F Siliciano, Avy Violari, Paul Palumbo, Susan H Eshleman
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81213 (2013)
In HIV-infected children, viral diversity tends to increase with age in the absence of antiretroviral treatment (ART). We measured HIV diversity in African children (ages 6-36 months) enrolled in a randomized clinical trial comparing two ART regimens
Externí odkaz:
https://doaj.org/article/4d0a11e1ab874213b822d302f0c4a539
Publikováno v:
Health Serv Res
OBJECTIVE: To discuss and develop difference‐in‐difference estimators for categorical outcomes and apply them to estimate the effect of the Affordable Care Act's Medicaid expansion on insurance coverage. DATA SOURCES: Secondary analysis of Survey
Autor:
Lindsay Allen, Evan Cole, Michael Sharbaugh, Anna Austin, Marguerite Burns, Chung-Chou Ho Chang, Sarah Clark, Dushka Crane, Peter Cunningham, Christine Durrance, Carrie Fry, Adam Gordon, Lindsey Hammerslag, Joo Yeon Kim, Susan Kennedy, Sunita Krishnan, Rachel Mauk, Jeff Talbert, Lu Tang, Julie M. Donohue, Andrew Barnes, Shamis Mohamoud, Marian P. Jarlenski, Adam J. Gordon, Chung-Chou H. Chang, Stefanie Junker, Katherine Ahrens, Anna E. Austin, Mary Joan McDuffie
Publikováno v:
Journal of Substance Use and Addiction Treatment. 149:209034
Autor:
Samantha Kuryla, Sharon Nachman, Hedy Teppler, Lynette Perdue, Steven A Spector, Carol Worrell, Lisa M. Frenkel, Terence Fenton, Pearl Samson, Steve Douglas, Carrie Fry, MariPat Toye, Brenda Homony, Bobbie Graham, Carmelita Alvero, Andrew Wiznia, Rohan Hazra, Scott Watson, Anthony Rodgers, Nan Zheng, Edward P. Acosta, Renee Browning, Nancy B. Tustin
Publikováno v:
The Lancet HIV. 5:e715-e722
BACKGROUND: Raltegravir is an integrase inhibitor approved for use in adults and children with HIV-1 infection, but there are no data on the long-term use of this medication in children. We aimed to assess the long-term safety, tolerability, pharmaco
Autor:
Mila Grossman, Rachel MacLean, Michal McDowell, Mladen Nisavic, Emily Sorg, Charles Masaki, Carrie Fry, Suzanne Bird, Felicia Smith, Scott Beach
Publikováno v:
Journal of the Academy of Consultation-Liaison Psychiatry. 63:S107
Autor:
Amy E. Krefman, Jody D. Ciolino, Ann K. Kan, Bruce Maki, Megan McHugh, Justin D. Smith, Jennifer Bannon, Allison J. Carroll, Patricia Bustamante, Carrie Frye, Brian Hitsman, Anya Day, Theresa L. Walunas
Publikováno v:
Contemporary Clinical Trials Communications, Vol 35, Iss , Pp 101199- (2023)
Background: The burden of cardiovascular disease (CVD) is particularly high in several US states, which include the state of Michigan. Hypertension and smoking are two major risk factors for mortality due to CVD. Rural Michigan is disproportionally a
Externí odkaz:
https://doaj.org/article/e562599bb4fd440fbb29d542765e23e6
Autor:
Andrew Wiznia, Sharon Nachman, Edward P. Acosta, Lihong Du, Hedy Teppler, Carol Worrell, Carrie Fry, Larissa Wenning, Chantelle Bennetto-Hood, Betsy Smith, Brenda Homony, Bobbie Graham, Matthew L. Rizk
Publikováno v:
Journal of clinical pharmacology. 55(7)
P1066 is an open-label study of raltegravir in HIV positive youth, ages 4 weeks-18 years. Here we summarize P1066 pharmacokinetic (PK) data and a population PK model for the pediatric chewable tablet and oral granules. Raltegravir PK parameters were